1. Hair cortisol is elevated in patients with erythropoietic protoporphyria and correlates with body mass index and quality of life. (1st May 2018) Authors: Suijker, I.; Savas, M.; van Rossum, E.F.C.; Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hair cortisol is elevated in patients with erythropoietic protoporphyria and correlates with body mass index and quality of life. (6th April 2018) Authors: Suijker, I.; Savas, M.; van Rossum, E.F.C.; Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome. Issue 5 (May 2021) Authors: Molema, F.; Haijes, H.A.; Janssen, M.C.; Bosch, A.M.; van Spronsen, F.J.; Mulder, M.F.; Verhoeven-Duif, N.M.; Jans, J.J.M.; van der Ploeg, A.T.; Wagenmakers, M.A.; Rubio-Gozalbo, M.E.; Brouwers, M.C.G.J.; de Vries, M.C.; Fuchs, S.; Langendonk, J.G.; Rizopoulos, D.; van Hasselt, P.M.; Williams, M. Journal: Clinical nutrition Issue: Volume 40:Issue 5(2021) Page Start: 3622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Osteoporosis in patients with erythropoietic protoporphyria. (1st December 2017) Authors: Biewenga, M.; Matawlie, R.H.S.; Friesema, E.C.H.; Koole‐Lesuis, H.; Langeveld, M.; Wilson, J.H.P.; Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Osteoporosis in patients with erythropoietic protoporphyria2. (22nd November 2017) Authors: Biewenga, M.; Matawlie, R.H.S.; Friesema, E.C.H.; Koole‐Lesuis, H.; Langeveld, M.; Wilson, J.H.P.; Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (February 2020) Authors: Sardh, E.; Gouya, L.; Rees, D.C.; Stein, P.; Stölzel, U.; Aguilera Peiro, P.; Bissell, D.M.; Bonkovsky, H.L.; Keel, S.; Parker, C.; Phillips, J.D.; Silver, S.; Windyga, J.; D'Avola, D.; Ross, G.; Stewart, P.; Ritchie, B.; Oh, J.; Harper, P.; Wang, J.D. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment for erythropoietic protoporphyria. (1st June 2015) Authors: Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment for erythropoietic protoporphyria. (2nd June 2015) Authors: Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment for erythropoietic protoporphyria. (2nd June 2015) Authors: Langendonk, J.G. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗